Promote Sponsor
verified SJR 1,934 · Q1 • database Scopus / SJR & Web of Science indexed
European Neuropsychopharmacology
Netherlands · Elsevier B.V.
workspace_premium Q1 — Pharmacology lock_open Open Access Unclaimed

European Neuropsychopharmacology

European Neuropsychopharmacology is a journal indexed in SJR in Pharmacology and Neurology (clinical) with an H index of 136. It has an SJR impact factor of 1,934 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,934.

European Neuropsychopharmacology focuses its scope in these topics and keywords: functioning, dopamine, calendar, system, response, receptor, patients, neuronal, monoamine, early, ...

ISSN: 0924-977X
Editorial: Elsevier B.V.
Category: Pharmacology
Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD
schedule Datos CoP · solo campos en BD
SJR Impact Factor trending_up
1,934 Q1
H-index 136
Tasa de Aceptación pie_chart
23% Selectiva
Fuente Acceptance_Rate
Tiempo a publicación hourglass_top
NPD
Campo Sin dato
Coste de Publicación (APC) payments
NPD Open Access
Ruta Non-OA 0 €

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

1,934

H-index

136

Docs (year)

150

Docs 3y

433

Total refs

5777

Cites 3y

1941

Citable 3y

289

Cites/Doc 2y

4.89

Ref/Doc

38.51

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Developmental processes and immunology in schizophrenia

View more

Vitamin E inhibits cellular accumulation of desipramine and prevents antidepressant induced beta-adrenoceptor down-regulation in vitro and in vivo

View more

MAO and COMT: basic functions and therapeutic indications

View more

Lymphocyte peripheral benzodiazepine receptor mRNA decreases in obsessive-compulsive disorder

View more

Long-term continuation therapy with the novel antipsychotic olanzapine: A review of the clinical experience

View more

L-5 Critical progress in MAO inhibition in the treatment of mood disorders

View more

Involvement of dynorphin in immobilization stress-induced antinociception in the mouse

View more

Inflammation and anti-inflammatory treatment strategies in Alzheimer's disease

View more

Gabapentin as monotherapy in the treatment of acute mania

View more

Free radical formation level in rabbit brain after experimental cranlocerebral trauma

View more

Effects of low-dose cholecystokinin on respiratory function in healthy volunteers

View more

Effects of calcium channel blockade on intravenous self-administration of ethanol in rats

View more
SHOW MORE ARTICLES

Effect of nicotine on sniffing induced by dopaminergic receptor stimulation

View more

Abnormalities of hypothalamus-pituitary-adrenal axis function and natural killer cell activity in Alzheimer's disease

View more

Comparative efficacy of moclobemide and imipramine on anxiety features in major depression- a meta-analysis of double blind comparative studies against placebo

View more

Combined pharmakotherapy (Tramadon and mianserin) in chronic pain syndrome

View more

Clinico-pharmacokinetic prognosis of prophylactic efficacy of carbamazepine, oxcarbazepine and sodium valproate in affective and schizoaffective disorders

View more

Changes of cerebrospinal fluid monoamine metabolites during long-term antidepressant treatment

View more

Changes in composition of phospholipids and fatty acids in rat brain during aging

View more

Calcium channel blockers prevent memory impairment induced by the beta-blockers acebutolol and metoprolol

View more

Blunted reaction to the citalopram challenge test in patients with major depression

View more

Antagonism of the 5-HT1A receptor stimulus in a conditioned taste aversion procedure

View more

An aminopyrimidine with potent affinity for both dopamine and serotonin reoeptors

View more

Ammonium acetate challenge in experimental chronic hepatic encephalopathy induces a transient increase of brain 5-HT release in vivo

View more

FAQS